Kazia Therapeutics Limited. Diluted Earnings Loss Per Share
Kazia Therapeutics Limited. (KZIA) reported Diluted Earnings Loss Per Share of -0.805 AUD/shares for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2026-03-30
| Period end | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 6 month as first filed | Diluted Earnings Loss Per Share 12 month | Diluted Earnings Loss Per Share 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -0.81 AUD/shares 6-K · filed 2026-03-30 | -0.01 AUD/shares 6-K · filed 2026-03-19 | ||
| 2025-06-30 | -0.04 AUD/shares 20-F · filed 2025-11-07 | |||
| 2024-12-31 | -2.46 AUD/shares 6-K · filed 2026-03-30 | -0.02 AUD/shares 6-K · filed 2025-06-10 | ||
| 2024-06-30 | -0.10 AUD/shares 20-F · filed 2025-11-07 | |||
| 2023-12-31 | -3.68 AUD/shares 6-K · filed 2024-03-27 | |||
| 2023-06-30 | -0.11 AUD/shares 20-F · filed 2025-11-07 | |||
| 2022-12-31 | -0.04 AUD/shares 6-K · filed 2025-06-10 | -9.33 AUD/shares 6-K/A · filed 2023-03-09 | ||
| 2022-06-30 | -0.19 AUD/shares 20-F · filed 2024-11-15 | -0.19 AUD/shares 20-F · filed 2022-10-17 | ||
| 2021-12-31 | -10.00 AUD/shares 6-K/A · filed 2023-03-09 | |||
| 2021-06-30 | -0.07 AUD/shares 20-F · filed 2023-10-26 | -7.16 AUD/shares 20-F · filed 2021-10-07 | ||
| 2020-06-30 | -0.17 AUD/shares 20-F · filed 2022-10-17 | -17.07 AUD/shares 20-F · filed 2020-10-22 | ||
| 2019-06-30 | -17.86 AUD/shares 20-F · filed 2021-10-07 | |||
| 2018-06-30 | -12.48 AUD/shares 20-F · filed 2020-10-22 | |||
| 2017-06-30 | -2.28 AUD/shares 20-F · filed 2019-10-21 | |||
| 2016-06-30 | -2.82 AUD/shares 20-F · filed 2018-10-24 |